| Zacks Company Profile for Laxai Pharma Ltd. (LAXAF : OTC) |
|
|
| |
| • Company Description |
| Laxai Pharma Ltd., formerly known as NexGen Biofuels Ltd., is a clinical research company. The Company, through its wholly owned subsidiary OSR Holding Corp., provides integrated services across the drug development spectrum in the United States. Its services include biostatistics, data management (EDC, Hybrid and Paper), CDISC consulting, medical writing, monitoring, regulatory, drug safety, and training. Laxai Pharma Ltd. is based in Tampa, Florida.
Number of Employees: |
|
|
| |
| • Price / Volume Information |
| Yesterday's Closing Price: $ |
Daily Weekly Monthly
 |
| 20 Day Moving Average: shares |
| Shares Outstanding: (millions) |
| Market Capitalization: $ (millions) |
| Beta: |
| 52 Week High: $0.00 |
| 52 Week Low: $0.00 |
| Short Interest Ratio: |
| |
% Price Change |
% Price Change Relative to S&P 500 |
| 4 Week |
% |
% |
| 12 Week |
% |
% |
| Year To Date |
% |
% |
|
|
|
|
| |
| • Address & Contact Information |
| Street Address |
Phone / Fax |
Email Address |
Web URL |
8905 REGENTS PARK DR SUITE 210
-
TAMPA,FL 33647
ISR |
ph: 813-428-3500
fax: 775-942-6642 |
None |
http://www.laxai.com |
|
|
| |
| • General Corporate Information |
Officers
J. Ram Ajjarapu - Chief Executive Officer & Director
A. S. N. Murty - Director
- - -
- - -
- - -
|
|
Peer Information
- (-)
- (-)
- (-)
- (-)
- (-)
- (-)
|
|
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: Medical Services
Sector: Medical
CUSIP: M6717V108
SIC: 2860
|
|
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: -
Next Expected EPS Date: -
|
|
Share - Related Items
Shares Outstanding:
Most Recent Split Date: 2.00 (0.25:1)
Beta:
Market Capitalization: $ (millions)
|
|
|
|
|
| |
| • EPS Information |
• Dividend Information |
| Analyst Coverage: No |
Dividend Yield: % |
| Current Fiscal Quarter EPS Consensus Estimate: $ |
Indicated Annual Dividend: $0.00 |
| Current Fiscal Year EPS Consensus Estimate: $ |
Payout Ratio: |
| Number of Estimates in the Fiscal Year Consensus: |
Change In Payout Ratio: |
| Estmated Long-Term EPS Growth Rate: % |
Last Dividend Paid: NA - $0.00 |
| Next EPS Report Date: - |
|
|
|
| |
